```json
{
"content": [
{
"type": "paragraph",
"content": "The Interventional Radiology Imaging System market encompasses advanced diagnostic and therapeutic imaging technologies used for minimally invasive procedures, such as angiography, embolization, and biopsies. These systems are critical for real-time guidance in vascular and non-vascular interventions, addressing rising global demand for precision-driven medical treatments. The market is witnessing robust industry expansion, driven by technological innovation and the increasing adoption of image-guided therapies in hospitals and specialty clinics."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Digital Subtraction Angiography (DSA)", "Cone Beam CT (CBCT)", "Others"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[1200, 1320, 1450, 1580, 1720, 1870, 2020, 2180, 2350, 2530, 2720, 2920, 3130], // DSA
[800, 880, 960, 1050, 1150, 1260, 1380, 1510, 1650, 1800, 1960, 2130, 2310], // CBCT
[400, 440, 480, 520, 560, 600, 640, 680, 720, 760, 800, 840, 880] // Others
]
}
},
{
"type": "paragraph",
"content": "The global Interventional Radiology Imaging System market size was valued at USD 2.8 billion in 2025, projected to reach USD 5.7 billion by 2033 at a CAGR of ~9.2%. Key growth outlook drivers include the surge in minimally invasive procedures, AI-integrated imaging advancements, and regulatory tailwinds in emerging markets. Market forecast highlights North America as the largest region, while Asia-Pacific is the fastest-growing due to rising healthcare infrastructure investments and a growing geriatric population. Competitive intensity is escalating as OEMs prioritize R&D for 3D imaging and portable system development, reshaping industry expansion trajectories."
}
]
}
```
